CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Porters five forces analysis
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Technological advancements
3.4.1.2. Rise in prevalence of diseases that require endotherapy devices
3.4.1.3. Rise in patient preference for minimally invasive surgeries
3.4.1.4. Shorter recovery time and minimal postoperative complications

3.4.2. Restrains

3.4.2.1. Dearth of trained physicians & endoscopists
3.4.2.2. Infections caused by few endotherapy
3.4.2.3. High costs associated with endotherapy devices

3.4.3. Opportunity

3.4.3.1. Unmet medical demands in the developing countries
3.4.3.2. Lucrative opportunities in the emerging economies

CHAPTER 4: ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast, by product

4.2. GI accessories

4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast, by country
4.2.3. Market size and forecast, by type
4.2.4. Biopsy forceps

4.2.4.1. Market size and forecast

4.2.5. Injection needles

4.2.5.1. Market size and forecast

4.2.6. Polypectomy snares

4.2.6.1. Market size and forecast

4.2.7. Graspers

4.2.7.1. Market size and forecast

4.2.8. Hemoclips

4.2.8.1. Market size and forecast

4.2.9. Other GI accessories

4.2.9.1. Market size and forecast

4.3. ERCP accessories

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by country
4.3.3. Market size and forecast, by type
4.3.4. Guidewires

4.3.4.1. Market size and forecast

4.3.5. Sphincterotome

4.3.5.1. Market size and forecast

4.3.6. Catheter

4.3.6.1. Market size and forecast

4.3.7. Extraction basket

4.3.7.1. Market size and forecast

4.3.8. Extraction balloon

4.3.8.1. Market size and forecast

4.3.9. Balloon dilators

4.3.9.1. Market size and forecast

4.3.10. Plastic stent

4.3.10.1. Market size and forecast

4.3.11. Metal stent

4.3.11.1. Market size and forecast

4.3.12. Other ERCP devices & accessories

4.3.12.1. Market size and forecast

4.4. Other endotherapy accessories

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by country
4.4.3. Market size and forecast, by type
4.4.4. Mouthpiece

4.4.4.1. Market size and forecast

4.4.5. Distal end cap

4.4.5.1. Market size and forecast

4.4.6. Polyp trap

4.4.6.1. Market size and forecast

4.4.7. Cleaning brush

4.4.7.1. Market size and forecast

4.4.8. Others

4.4.8.1. Market size and forecast

CHAPTER 5: ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET, BY COUNTRY

5.1. Overview

5.1.1. Market size and forecast, by country

5.2. China

5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast, by product

5.3. Japan

5.3.1. Key market trends and opportunities
5.3.2. Market size and forecast, by product

5.4. India

5.4.1. Key market trends and opportunities
5.4.2. Market size and forecast, by product

5.5. Singapore

5.5.1. Key market trends and opportunities
5.5.2. Market size and forecast, by product

5.6. Malaysia

5.6.1. Key market trends and opportunities
5.6.2. Market size and forecast, by product

5.7. Thailand

5.7.1. Key market trends and opportunities
5.7.2. Market size and forecast, by product

5.8. Rest of Asia-Pacific

5.8.1. Key market trends and opportunities
5.8.2. Market size and forecast, by product

CHAPTER 6: COMPANY PROFILES

6.1. Boston Scientific Corporation

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments

6.2. CONMED Corporation

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance

6.3. FUJIFILM Holdings Corporation

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.3.5. Business performance
6.3.6. Key strategic moves and developments

6.4. HOYA Corporation

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Business performance

6.5. Johnson & Johnson (Ethicon, Inc.)

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance

6.6. KARL STORZ GmbH & Co KG

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio

6.7. Medtronic Plc.

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance

6.8. Olympus Corporation

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance

6.9. Stryker Corporation

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance

6.10. Smith & Nephew Plc.

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance